Viral cell invasion inhibitors
A viral cell invasion inhibitor using plant extracts from eyebright, fenugreek, buckwheat, okra, and cinnamon prevents viral entry into host cells, effectively blocking SARS-CoV-2 and H5N1 influenza, addressing the inadequacies of existing prevention methods.
TW202631172APending Publication Date: 2026-08-01YAKULT HONSHA KK
0 Cites 0 Cited by
Patent Information
- Application Number
- TW114143885
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-13
- Filing Date
- 2025-11-11
- Publication Date
- 2026-08-01
AI Technical Summary
Technical Problem
Existing methods are inadequate in preventing viral infections by inhibiting the invasion of viruses into host cells, as viruses lack the ability to self-replicate and instead multiply within host cells by binding to cell surface receptors.
Method used
Development of a viral cell invasion inhibitor comprising extracts from eyebright, fenugreek, buckwheat, okra, cinnamon, and almond, which bind to viral membrane proteins or cover the viral surface to prevent cell invasion.
Benefits of technology
The inhibitor effectively blocks viral entry into cells, preventing infections with high efficacy against viruses such as SARS-CoV-2 and influenza, particularly the H5N1 subtype, with minimal toxicity to host cells.
✦ Generated by Eureka AI based on patent content.
Abstract
The objective of this invention is to provide a viral cell invasion inhibitor that prevents viruses from entering cells and thus prevents viral infections. The viral cell invasion inhibitor that solves the objective of this invention is characterized by containing at least one of the following: eyebright extract, fenugreek extract, buckwheat extract, okra extract, cinnamon extract, barley extract, and alpinia extract.
Need to check novelty before this filing date? Find Prior Art